Cite
HARVARD Citation
Bygrave, C. et al. (2021). Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma. British journal of haematology. pp. 551-555. [Online].